Figure 1.

Ropivacaine inhibits the proliferation and migration of HCT116 and SW620 cells, and the invasion ability. (a). SW620 and different doses of ropivacaine after treatment, and the results of MTT detection were expressed by absorbance values at 562 nm; (b). HCT116 and different doses of ropivacaine after treatment, the results of MTT detection were expressed by absorbance values at 562 nm; (c). The result of nuclear staining of two colon cancer cells treated with different doses by DAPI; (d). Changes in cell migration within 24 h; (e). Transwell experiment results; (f). Quantitative statistical results of cell migration experiments; G. Transwell experiment to quantify statistical results. ‘*’ indicates a significant difference compared with the control group (P < 0.05). ‘**’ indicates a significant difference (P < 0.01), the same below